Literature DB >> 8970587

Dysplastic nevi and other risk markers for melanoma.

J Seykora1, D Elder.   

Abstract

Risk markers for cancer are genetic or behavioral attributes that are statistically associated with increased incidence of cancer. Risk may be assessed either in case-control studies, or in cohort studies in which individuals with particular attributes are followed and cancer risk is determined by direct observation. Both of these methods have been used to determine the major risk markers for melanoma. The single most important risk marker is the presence on the skin of dysplastic nevi. Dysplastic nevi may be regarded as intermediate lesions of tumor progression, in that approximately 30% of melanomas arise in association with a precursor nevus, which is most commonly dysplastic. However, paradoxically, because they are vastly more numerous than melanoma, most dysplastic nevi are stable lesions that do not progress. Additional important melanoma risk factors include a family and/or personal history of melanoma. A third major category of risk markers includes indicators of acute and chronic exposure to the sun, including freckles, actinic skin damage, and a history of sunburn. Evaluation of these markers in oncological patients and their first-degree relatives can identify a population of individuals whose risk for melanoma ranges from several-fold to more than 100-fold greater than that of random population members. Efforts directed at early diagnosis in these individuals can result in recognition of melanomas in their early, curable stages.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8970587

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  6 in total

1.  Embryonic signaling in melanoma: potential for diagnosis and therapy.

Authors:  Luigi Strizzi; Katharine M Hardy; Gina T Kirsammer; Pedram Gerami; Mary J C Hendrix
Journal:  Lab Invest       Date:  2011-04-04       Impact factor: 5.662

Review 2.  Genetics of melanocytic nevi.

Authors:  Mi Ryung Roh; Philip Eliades; Sameer Gupta; Hensin Tsao
Journal:  Pigment Cell Melanoma Res       Date:  2015-11       Impact factor: 4.693

Review 3.  Cutaneous melanoma: From pathogenesis to therapy (Review).

Authors:  Giulia C Leonardi; Luca Falzone; Rossella Salemi; Antonino Zanghì; Demetrios A Spandidos; James A Mccubrey; Saverio Candido; Massimo Libra
Journal:  Int J Oncol       Date:  2018-02-27       Impact factor: 5.650

4.  Genome-wide analysis of gene and protein expression of dysplastic naevus cells.

Authors:  Linda Gao; Frans A van Nieuwpoort; Jacoba J Out-Luiting; Paul J Hensbergen; Femke A de Snoo; Wilma Bergman; Remco van Doorn; Nelleke A Gruis
Journal:  J Skin Cancer       Date:  2012-11-28

5.  B-Raf specific antibody responses in melanoma patients.

Authors:  Joachim Fensterle; Jürgen C Becker; Tamara Potapenko; Veronika Heimbach; Claudia S Vetter; Eva B Bröcker; Ulf R Rapp
Journal:  BMC Cancer       Date:  2004-09-12       Impact factor: 4.430

6.  Translational significance of Nodal, Cripto-1 and Notch4 in adult nevi.

Authors:  Luigi Strizzi; Naira V Margaryan; Pedram Gerami; Zahra Haghighat; Paul W Harms; Gabriele Madonna; Gerardo Botti; Paolo A Ascierto; Mary J C Hendrix
Journal:  Oncol Lett       Date:  2016-06-21       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.